This report, the ninth report launched jointly by ECDC and the WHO Regional Office for Europe, presents the latest data on the status of tuberculosis in Europe.
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.
A multi-country cluster of multidrug-resistant tuberculosis (MDR TB) involving 28 migrants has been delineated by whole genome sequencing (WGS) in migrants recently having arrived from countries in the Horn of Africa.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 9-15 April 2017 and includes updates on hepatitis A, influenza, MDR TB, measles, yellow fever, Zika, dengue and Chikungunya.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2–8 April 2017 and includes updates on influenza, MDR TB and Measles.